Thomas Klaritch Sells 82,532 Shares of HCP, Inc. (HCP) Stock

Share on StockTwits

HCP, Inc. (NYSE:HCP) COO Thomas Klaritch sold 82,532 shares of HCP stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $29.51, for a total transaction of $2,435,519.32. Following the transaction, the chief operating officer now directly owns 256,280 shares in the company, valued at $7,562,822.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of HCP stock traded up $1.15 during trading on Thursday, reaching $30.23. The company’s stock had a trading volume of 7,406,607 shares, compared to its average volume of 3,562,895. The company has a debt-to-equity ratio of 1.21, a quick ratio of 0.48 and a current ratio of 0.48. The stock has a market capitalization of $13.67 billion, a P/E ratio of 15.50, a price-to-earnings-growth ratio of 7.33 and a beta of 0.23. HCP, Inc. has a 1-year low of $21.48 and a 1-year high of $30.26.

HCP (NYSE:HCP) last announced its quarterly earnings data on Wednesday, October 31st. The real estate investment trust reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.10. The firm had revenue of $456.00 million during the quarter, compared to analysts’ expectations of $456.59 million. HCP had a net margin of 9.16% and a return on equity of 3.06%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.48 earnings per share. On average, research analysts forecast that HCP, Inc. will post 1.82 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 20th. Investors of record on Monday, November 5th were issued a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.90%. The ex-dividend date of this dividend was Friday, November 2nd. HCP’s dividend payout ratio (DPR) is currently 75.90%.

Several hedge funds have recently made changes to their positions in HCP. Mount Yale Investment Advisors LLC acquired a new position in shares of HCP in the second quarter valued at approximately $104,000. Piedmont Investment Advisors LLC acquired a new position in HCP during the 2nd quarter worth approximately $142,000. Peoples Financial Services CORP. grew its holdings in HCP by 87.7% during the 3rd quarter. Peoples Financial Services CORP. now owns 6,100 shares of the real estate investment trust’s stock worth $161,000 after acquiring an additional 2,850 shares in the last quarter. Wetherby Asset Management Inc. acquired a new position in HCP during the 3rd quarter worth approximately $200,000. Finally, Lourd Capital LLC acquired a new position in HCP during the 3rd quarter worth approximately $211,000. Hedge funds and other institutional investors own 90.00% of the company’s stock.

HCP has been the topic of a number of analyst reports. ValuEngine raised shares of HCP from a “hold” rating to a “buy” rating in a research note on Monday, November 12th. Mizuho reaffirmed a “buy” rating and set a $29.00 target price on shares of HCP in a research note on Monday, August 13th. Bank of America lifted their price target on shares of HCP from $27.50 to $28.00 and gave the company a “buy” rating in a research report on Monday, September 17th. Morgan Stanley lifted their price target on shares of HCP from $23.50 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, August 16th. Finally, BMO Capital Markets reiterated a “hold” rating and set a $27.00 price target on shares of HCP in a research report on Wednesday, October 31st. Three analysts have rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $26.75.

TRADEMARK VIOLATION NOTICE: “Thomas Klaritch Sells 82,532 Shares of HCP, Inc. (HCP) Stock” was posted by Zolmax and is the sole property of of Zolmax. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at https://zolmax.com/investing/thomas-klaritch-sells-82532-shares-of-hcp-inc-hcp-stock/2745608.html.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

See Also: Cost of Capital

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: Analysts Expect Nlight Inc  Will Announce Quarterly Sales of $46.93 Million
Zacks: Analysts Expect Nlight Inc Will Announce Quarterly Sales of $46.93 Million
CMC Markets  Receives “Buy” Rating from Peel Hunt
CMC Markets Receives “Buy” Rating from Peel Hunt
HALFORDS GRP PL/ADR  Rating Increased to Hold at Zacks Investment Research
HALFORDS GRP PL/ADR Rating Increased to Hold at Zacks Investment Research
Cairn Energy’s  Overweight Rating Reiterated at Barclays
Cairn Energy’s Overweight Rating Reiterated at Barclays
Wells Fargo & Co  Shares Bought by Auxier Asset Management
Wells Fargo & Co Shares Bought by Auxier Asset Management
B. Riley Financial Inc. Increases Position in Spectrum Pharmaceuticals, Inc.
B. Riley Financial Inc. Increases Position in Spectrum Pharmaceuticals, Inc.


Leave a Reply

 
© 2006-2018 Zolmax.